Vertebrate collagenase inhibitor. II. Tetrapeptidyl hydroxamic acids.
S Odake, T Okayama, M Obata, T Morikawa, S Hattori, H Hori, Y Nagai
Index: Chem. Pharm. Bull. Tokyo 39 , 1489-1494, (1991)
Full Text: HTML
Abstract
To develop a potent and specific collagenase inhibitor, a series of tetrapeptidyl hydroxamic acids were synthesized, based on the previous findings with tripeptidyl derivatives (Chem. Pharm. Bull., 38, 1007-1011, 1990). Among the series of tetrapeptidyl derivatives synthesized, R-Gly-Pro-Leu-Ala-NHOH and R-Gly-Pro-D-Leu-D-Ala-NHOH were found to be highly specific and potent inhibitors against vertebrate collagenase with an IC50 of 10(-6) M order, where R stands for Boc or acyl group. Analysis of their structure-activity relationships showed a characteristic feature of the substrate-binding site of collagenase as follows: 1) the S1 subsite forms a shallow hydrophobic pocket, although glycine residue corresponds to the subsite of the natural collagen substrate: 2) the S2 subsite constitutes a bulky pocket with less requirement for hydrophobicity: 3) the S3 subsite preferentially accommodates Pro residue: and 4) the accommodation of the P4-P1 subsites of peptidyl collagenase inhibitor to the S4-S1 subsites is required to form a tight binding of its hydroxamic acid moiety to the zinc ion at the catalytic site of the enzyme. The introduction of an enantiometric dipeptide unit, D-Leu-D-Ala, to the P2-P1 subsites demonstrated an increased binding capacity to the extended S4-S1 subsites of collagenase, thus providing proteinase-resistant inhibitor.
Related Compounds
Related Articles:
Impaired Focal Adhesion Kinase-Grb2 Interaction during Elevated Activity in Hippocampal Neurons.
2015-01-01
[Int. J. Mol. Sci. 16 , 15659-69, (2015)]
Inhibition of matrix metalloproteinases by peptidyl hydroxamic acids.
1994-03-30
[Biochem. Biophys. Res. Commun. 199 , 1442-6, (1994)]
1998-04-01
[Proteins 31 , 42-60, (1998)]
1996-12-01
[J. Endod. 22 , 668-673, (1996)]
Inhibition of corneal ulceration by tetrapeptidyl hydroxamic acid.
1995-01-01
[Jpn. J. Ophthalmol. 39 , 35-42, (1995)]